Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Matcha, a finely ground powder of specially grown and processed green tea leaves (Camellia sinensis), is increasingly discussed for its potential to support anxiety disorders. The justification for its use is based on emerging scientific evidence rather than long-standing traditional use specifically for anxiety. Matcha is rich in L-theanine, an amino acid known to promote relaxation without sedation. Several studies suggest that L-theanine can modulate aspects of brain function in humans, potentially reducing stress and anxiety. For example, randomized controlled trials have shown that L-theanine supplementation can lower subjective stress and anxiety in both acute and chronic settings.

Additionally, matcha contains caffeine, which may counteract some of the sedative effects of L-theanine. However, the unique combination of L-theanine and caffeine in matcha is proposed to promote a state of "alert calmness." A small number of human studies and animal models provide preliminary support for matcha’s anxiolytic effects, but the evidence is still limited and not robust. There is a lack of large-scale, high-quality clinical trials directly examining matcha (as opposed to purified L-theanine).

In summary, while there is growing scientific interest and some early evidence, matcha cannot be considered a proven treatment for anxiety disorders. Its use is justified by scientific rationale and limited preliminary evidence, meriting a modest evidence rating.

More about Matcha
More about Anxiety Disorders

Other ingredients used for Anxiety Disorders

Other health conditions supported by Matcha

Products containing Matcha